Medicare approval is the holy grail in this business. Once you you get medicare, all the other private compani es follow through. Rosetta is offering a company that can target cancer cells at their source using a variety of weapons. As a physician, I often meet patients who have a tumor, any my first question is , what is the primary? This product will provide me the way to attack this cancer, as a primary basal cell carcinoma requires different attack than a metastatic colon cancer. This product is an elegant solution to a long standing problem. Medicare approved, so the rest will follow through. This is an important test that will save lives best of all...
ED doc huh? cut the crap just because medicare approved it means nothing. Private insurance will only approve something if it saves them money !! if there is other test out there even though it is not the best but has good sensitivity and specificty and is cheaper for the insurance, they will continue to refuse to pay for new test.
Lastly how is this one test suppose to diagnose all sorts of cancers at inception? each malignancy has its own different origin surely you would know that if you took biology forget medical school.
As a ER doc you see all sorts of cancers? oh puh-lease they dont have the foggiest clue about wtf is going on. You can scan the guy upside down/sideways without tissue diagnosis you do not know wtf it is most of the time infection vs malignancy. There are certain clues that push judgement in a certain direction. And any test whether its a biopsy, blood test, flow cytometry, bone marrow will take days to get results. you keep the guy in the ER till then?
P.S i do not own this stock nor do i plan to, too rich for my blood i am just a renal fellow for now
Funny to read a renal fellow piling in on an ER doctor. What the ER doc says regarding medicare approval is TRUE. Medicare approval is the toughest one to get. You can check with your Attending regarding this. Why don't you check with the oncologist or the pathologist in your hospital if there is any other test with similar or better sensitivity and specificity to diagnose CUP ?
In laymen terms it boils down to this....
When you get cancer you need to find the source. For example, you may have a ct scan which shows you have a brain tumor but it originally was a skin cancer or liver cancer. When your pathologists looks at the slide from the sample he/she may not be able to detect the source. this only from a few rare cases, most of the time they can tell just by reading the slide. If they cannot tell, then they'll send the slide to Rosetta to have this test done to get a definite answer from were the cancer originated so they can proceed with the proper treatment. No pump - my wife just read the pdf's from the website and explained to me how the process works. The company estimates there are 1,000,000 people world wide who can benefit from MiReview alone. The other tests like lung,kidney and other are not approved by medicare yet but should be soon based on the efficacy results on the site. they work and are proven to work but need medicare to cover them. In addition they have other tests in the pipe which they are working on but have not established efficacy.
This is what Aegis knows that's why they gave 10x pps from 10 days ago in tonights second offering. Look at the facts people not the short seller hype and bash. I'm buying double fisted tomorrow.
Thanks Rod! I'm aware of how large the market is, but have no idea what the charges for the procedure is. Just threw a number out there and looking for input. Anyway, the more I get into it the better this one looks. I'll be rooting for the longs hope I can own a some too, at a good price. lol
as a physician, I can tell you first hand that medicare approved expenses are golden. Example 1: maam, your mother is 98 and on a tracheostomy, she has minimal mental function at her baseline, do you wish to make her DNR? (do not resuscitate) No, do everything you can, make her live....What follows is a two week ICU stay, peg tube, foley catheter in her bladder, and the patient dies two weeks later suffering a lot more than she should have.
I see this stock as different. Maybe the green light provides targeted therapies, preventing cancer patients from getting to that end stage, where all of us whither. This is a good test, a moral choice, and I hope it prevents unnecessary deaths
Agreed. Great potential outside the US too, once we get a foothold in the US I imagine it will spread globally. Also great pipeline and other tests ready for use. MicroRNA is the way forward
Contains all their tests, also pipeline here